The Journal of Organic Chemistry
Article
57.6, 21.0, 13.9; 19F NMR (376 MHz, CDCl3): δ −81.86 (tt, J = 9.6,
2.4 Hz, 3F), −117.34 (dt, J = 248.9, 12.9 Hz, 1F), −122.75 to −122.90
(m, 2F), −124.57 (dt, J = 248.9, 11.6 Hz, 1F), −126.32 to −128.10
(m, 2F); HRMS (ESI/[M + H]+) calcd. for C18H17F9N3O3S:
526.0841. Found 526.0840.
dichloroethane (200 μL, [sulfinyl imine] = 0.75 M). The vial was
sealed and removed from the glovebox. The reaction vial was then
placed in a temperature-controlled oil bath preset to 50 °C. After the
solution was stirred for 24 h, the vial was removed from the oil bath
and cooled to ambient temperature before the reaction vessel was
unsealed. The crude mixture was purified directly by chromatography.
Ethyl (S)-2-(2-(1-Benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-(((S)-
(perfluorobutyl)sulfinyl)amino)acetate (11j). The general procedure
was followed with perfluorobutanesulfinyl imino ester 9 (55.1 mg,
0.150 mmol, 1.0 equiv) and 1-benzyl-4-phenyl-1H-1,2,3-triazole34a
(70.6 mg, 0.300 mmol, 2.0 equiv). Preparative thin-layer silica gel
chromatography using 50% Et2O/pentane provided the first step of
the purification process. Pure product was then obtained by C18
reverse phase column chromatography with loading of the isolated
material onto the column as a solution in 1 mL of DMSO. Reverse
phase purification was performed with 15.5 g of reverse phase media
and a 95 column volume gradient from 10 to 65% CH3CN:H2O
containing 0.1% TFA. Fractions containing product were combined
and diluted with sat. aq. NaHCO3 (50 mL) and extracted with CH2Cl2
(3 × 100 mL). The combined organic layers were then washed with
sat. aq. NaHCO3 (50 mL) and brine (50 mL), dried over MgSO4, and
concentrated to afford the product 11j (52.1 mg, 58% yield) as a
colorless oil. IR (film): 1738, 1352, 1196, 1138, 1014, 763, 721, 692,
Ethyl (S)-2-(5-Methoxy-2-(1H-pyrazol-1-yl)phenyl)-2-(((S)-
(perfluorobutyl)sulfinyl)amino)acetate (11g). The general procedure
was followed with perfluorobutanesulfinyl imino ester 9 (55.1 mg,
0.150 mmol, 1.0 equiv) and 1-(4-methoxyphenyl)-1H-pyrazole33a
(52.3 mg, 0.300 mmol, 2.0 equiv). Purification by preparative thin-
layer silica gel chromatography using 25% EtOAc/hexanes afforded
the product 11g (38.3 mg, 47% yield) as a light yellow oil. IR (film):
1740, 1523, 1196, 1138, 1043, 1018, 943, 864, 816, 746, 723, 692, 613,
1
435 cm−1; H NMR (500 MHz, CDCl3): δ 7.69 (d, J = 1.9 Hz, 1H),
7.58 (d, J = 2.2 Hz, 1H), 7.39 (d, J = 8.8 Hz, 1H), 7.23 (d, J = 8.7 Hz,
1H), 7.00 (d, J = 2.8 Hz, 1H), 6.95 (dd, J = 8.7, 2.8 Hz, 1H), 6.43 (t, J
= 2.2 Hz, 1H), 5.36 (d, J = 8.8 Hz, 1H), 4.00−3.88 (m, 2H), 3.85 (s,
3H), 1.09 (t, J = 7.2 Hz, 3H); 13C{1H} NMR (151 MHz, CDCl3): δ
168.9, 159.7, 140.8, 134.4, 131.9, 131.0, 127.2, 116.7, 115.0, 120.4−
106.4 (m), 107.4, 62.4, 57.3, 55.8, 13.9; 19F NMR (471 MHz, CDCl3):
δ −81.87 (t, J = 9.5 Hz, 3F), −117.38 (dt, J = 249.2, 13.2 Hz, 1F),
−122.71 to −122.88 (m, 2F), −124.49 (ad, J = 249.2, 1F), −126.48 to
−127.98 (m, 2F); HRMS (ESI/[M + H]+) calcd. for C18H17F9N3O4S:
542.0791. Found 542.0790.
1
581 cm−1; H NMR (500 MHz, CDCl3): δ 7.67 (s, 1H), 7.42−7.28
Ethyl (S)-2-(5-Acetyl-2-(1H-pyrazol-1-yl)phenyl)-2-(((S)-
(perfluorobutyl)sulfinyl)amino)acetate (11h). The general procedure
was followed with perfluorobutanesulfinyl imino ester 9 (55.1 mg,
0.150 mmol, 1.0 equiv) and 1-(4-(1H-pyrazol-1-yl)phenyl)ethan-1-
one33b (55.9 mg, 0.300 mmol, 2.0 equiv). Purification by preparative
thin-layer silica gel chromatography using 25% EtOAc/hexanes
afforded the product 11h (50.6 mg, 61% yield) as a light yellow
waxy solid. IR (film): 1726, 1697, 1607, 1524, 1395, 1191, 1137, 1033,
(m, 10H), 5.78 (d, J = 8.0 Hz, 1H), 5.59 (d, J = 14.8 Hz, 1H), 5.55 (d,
J = 14.8 Hz, 1H), 4.01−3.92 (m, 2H), 1.03 (t, J = 7.1 Hz, 3H);
13C{1H} NMR (151 MHz, CDCl3): δ 169.9, 147.4, 135.4, 134.4,
130.4, 130.1, 129.3, 129.3, 129.1, 129.1, 128.3, 122.0, 120.4−106.2
(m), 62.1, 58.6, 54.5, 13.8; 19F NMR (471 MHz, CDCl3): δ −81.88 (t,
J = 9.5 Hz, 3F), −117.99 (dt, J = 249.0, 12.6 Hz, 1F), −122.03 to
−123.54 (m, 2F), −123.56 (ad, J = 249.0 Hz, 1F), −126.52 to
−127.93 (m, 2F); HRMS (ESI/[M + H]+) calcd. for C23H20F9N4O3S:
603.1107. Found 603.1108.
1
943, 759, 746, 722, 692, 613, 514, 457 cm−1; H NMR (500 MHz,
CDCl3): δ 8.08 (d, J = 2.0 Hz, 1H), 8.04 (dd, J = 8.2, 2.0 Hz, 1H),
7.76 (d, J = 2.2 Hz, 1H), 7.74 (d, J = 2.0 Hz, 1H), 7.44 (d, J = 8.2 Hz,
1H), 7.40 (d, J = 9.1 Hz, 1H), 6.51 (t, J = 2.2 Hz, 1H), 5.58 (d, J = 9.1
Hz, 1H), 4.00−3.88 (m, 2H), 2.63 (s, 3H), 1.07 (t, J = 7.1 Hz, 3H);
13C{1H} NMR (151 MHz, CDCl3): δ 196.3, 168.7, 141.9, 141.8,
136.6, 132.9, 132.3, 130.5, 129.8, 124.8, 120.3−106.4 (m), 108.6, 62.5,
58.3, 26.8, 13.9; 19F NMR (471 MHz, CDCl3): δ −82.10 (t, J = 9.5
Hz, 3F), −117.80 (dt, J = 248.9, 13.5 Hz, 1F), −122.93 to −123.09
(m, 2F), −124.53 (ad, J = 248.9 Hz, 1F), −126.72 to −128.91 (m,
2F); HRMS (ESI/[M + H]+) calcd. for C19H17F9N3O4S: 554.0791.
Found 554.0793.
Ethyl (S)-2-(4-Methyl-2-(1H-pyrazol-1-yl)phenyl)-2-(((S)-
(perfluorobutyl)sulfinyl)amino)acetate (11i). The general procedure
was followed with perfluorobutanesulfinyl imino ester 9 (55.1 mg,
0.150 mmol, 1.0 equiv) and 1-(m-tolyl)-1H-pyrazole33a (47.5 mg,
0.300 mmol, 2.0 equiv). Purification by flash column chromatography
(10−20% EtOAc in hexanes gradient) afforded the product 11i (60.1
mg, 76% yield) as a light yellow oil. IR (film): 1738, 1519, 1394, 1351,
1194, 1138, 1101, 1014, 955, 859, 746, 722, 692, 619, 580, 437 cm−1;
1H NMR (600 MHz, CDCl3): δ 7.71 (d, J = 1.8 Hz, 1H), 7.67 (d, J =
2.2 Hz, 1H), 7.38−7.35 (m, 2H), 7.23 (d, J = 7.8 Hz, 1H), 7.14 (s,
1H), 6.46 (t, J = 2.2 Hz, 1H), 5.40 (d, J = 8.9 Hz, 1H), 3.98−3.88 (m,
2H), 2.40 (s, 3H), 1.08 (t, J = 7.1 Hz, 3H); 13C{1H} NMR (151 MHz,
CDCl3): δ 169.2, 141.1, 140.4, 138.5, 131.9, 130.6, 129.7, 129.6, 126.1,
120.4−106.4 (m), 107.6, 62.3, 57.6, 21.1, 14.0; 19F NMR (376 MHz,
CDCl3): δ −81.87 (tt, J = 9.4, 2.6 Hz, 3F), −117.57 (dt, J = 249.1,
13.0 Hz, 1F), −122.72 to −122.89 (m, 2F), −124.33 (dt, J = 249.1,
12.2 Hz, 1F), −126.33 to −128.10 (m, 2F); HRMS (ESI/[M + H]+)
calcd. for C18H17F9N3O3S: 526.0841. Found 526.0842.
Ethyl (S)-2-(2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-5-methoxyphenyl)-
2-(((S)-(perfluorobutyl)sulfinyl)amino)acetate (11k). The general
procedure was followed with perfluorobutanesulfinyl imino ester 9
(55.1 mg, 0.150 mmol, 1.0 equiv) and 1-benzyl-4-(4-methoxyphenyl)-
1H-1,2,3-triazole (79.6 mg, 0.300 mmol, 2.0 equiv). Preparative thin-
layer silica gel chromatography using 50% Et2O/pentane provided the
first step in the purification process. Pure product was then obtained
by C18 reverse phase column chromatography with loading of the
isolated material onto the column as a solution in 1 mL of DMSO.
Reverse phase purification was performed with 15.5 g of reverse phase
media and an 80 column volume gradient from 10 to 70%
CH3CN:H2O containing 0.1% TFA. Fractions containing product
were combined and diluted with sat. aq. NaHCO3 (50 mL) and
extracted with CH2Cl2 (3 × 100 mL). The combined organic layers
were then washed with sat. aq. NaHCO3 (50 mL) and brine (50 mL),
dried over MgSO4, and concentrated to afford the product 11k (53.0
mg, 56% yield) as a yellow oil. IR (film): 1738, 1615, 1493, 1459,
1
1351, 1196, 1138, 864, 814, 746, 721, 693, 580 cm−1; H NMR (400
MHz, CDCl3): δ 7.59 (s, 1H), 7.41−7.30 (m, 7H), 6.93 (d, J = 2.6 Hz,
1H), 6.88 (dd, J = 8.6, 2.6 Hz, 1H), 5.73 (d, J = 7.9 Hz, 1H), 5.58 (d, J
= 14.9 Hz, 1H), 5.53 (d, J = 14.9 Hz, 1H), 4.01−3.93 (m, 2H), 3.81 (s,
3H), 1.03 (t, J = 7.1 Hz, 3H); 13C{1H} NMR (151 MHz, CDCl3): δ
169.8, 160.0, 147.3, 136.8, 134.4, 131.5, 129.3, 129.0, 128.3, 121.8,
121.5, 115.6, 114.7, 120.4−106.4 (m), 62.2, 58.4, 55.5, 54.5, 13.8; 19F
NMR (376 MHz, CDCl3): δ −81.85 (t, J = 9.6 Hz, 3F), −117.85 (dt, J
= 249.0, 13.0 Hz, 1F), −121.83 to −123.66 (m, 2F), −123.74 (ad, J =
249.0 Hz, 1F), −126.35 to −128.08 (m, 2F); HRMS (ESI/[M + H]+)
calcd. for C24H22F9N4O4S: 633.1213. Found 633.1214.
Ethyl (S)-2-(2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-5-methylphenyl)-2-
(((S)-(perfluorobutyl)sulfinyl)amino)acetate (11l). The general pro-
cedure was followed with perfluorobutanesulfinyl imino ester 9 (55.1
mg, 0.150 mmol, 1.0 equiv) and 1-benzyl-4-(p-tolyl)-1H-1,2,3-triazole
(74.8 mg, 0.300 mmol, 2.0 equiv). Preparative thin-layer silica gel
chromatography using 50% Et2O/pentane provided the first step in
the purification process. Pure product was then obtained by C18
reverse phase column chromatography with loading of the isolated
material onto the column as a solution in 1 mL of DMSO. Reverse
General Procedure for the Synthesis of Arylglycines 11j−
11m. In a N2-filled glovebox, perfluorobutanesulfinyl imino ester 9
(55.1 mg, 0.150 mmol, 1.0 equiv), the indicated 1-benzyl-4-aryl-1H-
1,2,3-triazole (10j−10m)34 (0.300 mmol, 2.0 equiv), [Cp*RhCl2]2
(9.3 mg, 0.015 mmol, 0.10 equiv), AgB(C6F5)4 (62.0 mg, 0.060 mmol,
0.40 equiv, 23.8% w/w toluene), and AgOAc (5.0 mg, 0.030 mmol,
0.20 equiv) were added to a 0.5−2.0 mL microwave vial equipped with
a triangular magnetic stir bar, followed by the addition of 1,2-
H
J. Org. Chem. XXXX, XXX, XXX−XXX